National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 13563 [2015-05826]

Download as PDF 13563 Federal Register / Vol. 80, No. 50 / Monday, March 16, 2015 / Notices ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Type of respondent NICHD Grantee ............................................................................................... NIDCD Grantee ............................................................................................... NIMH Grantee .................................................................................................. NINDS Grantee ................................................................................................ NCI Grantee ..................................................................................................... NIEHS Grantee ................................................................................................ 200 200 200 200 400 200 Dated: March 5, 2015. Joellen M. Austin, Associate Director for Management, NIEHS, NIH. Dated: March 10, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–05927 Filed 3–13–15; 8:45 am] [FR Doc. 2015–05826 Filed 3–13–15; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Submission for OMB Review; 30-Day Comment Request: Outcome Evaluation of the Broadening Experiences in Scientific Training (BEST) Program (OD) Rmajette on DSK2VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID SBIR—Technology Transfer Direct Phase II (SBIR–TT) (R44). Date: April 7, 2015. Time: 11:00 a.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892, (Telephone Conference Call). Contact Person: Thomas F. Conway, Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers, Rockville, MD 20892, 240–669–5069, thomas.conway@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) VerDate Sep<11>2014 14:09 Mar 13, 2015 Jkt 235001 Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the Office of Strategic Coordination, an office of the Division of Program Coordination, Planning, and Strategic Initiatives, within the Office of the Director at the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on August 26, 2014, (79 FR 50921) and allowed 60-days for public comment. During the 60-day comment period, two requests for information were received. Both individuals requested the data collection plans and the data collection instruments and one also asked for background information. In response to these two requests, electronic copies of the following surveys were emailed: Entrance, Interim, Exit, and Post-Exit. Additionally, both individuals were provided with a brief overview of the program and a link to the NIH Web site that contains detailed information about the BEST program and the awardees. No additional comments were received from the two individuals who requested this information. The purpose of this notice is to allow an additional 30 days for public comment. The Office of Strategic Coordination (OSC), an office SUMMARY: PO 00000 Frm 00050 Fmt 4703 Sfmt 4703 Number of responses per respondent 1 1 1 1 1 1 Average time per response (in hours) Total annual burden hour 30/60 30/60 30/60 30/60 30/60 30/60 100 100 100 100 200 100 of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), within the Office of the Director (OD) at the National Institutes of Health (NIH) may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment due date: Comments regarding this information collection are best assured of having their full effect if received within 30-days of the date of this publication. DATES: To request more information on the proposed project or to obtain a copy of the data collection plans and instruments, contact Dr. Patricia Labosky, Office of Strategic Coordination, Division of Program Coordination, Planning, and Strategic Initiatives, Office of the Director, NIH, 1 Center Drive, MSC 0189, Building 1, Room 214A, Bethesda, MD 20892–0189. Telephone: 301–594–4863. Fax: 301– 435–7268. or email your request, including your address to: Workforce_Award@mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Outcome Evaluation of the Broadening Experiences in Scientific Training (BEST) Program (OD), 0925–NEW, the Office of Strategic Coordination (OSC), an office of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), within the Office of FOR FURTHER INFORMATION CONTACT: E:\FR\FM\16MRN1.SGM 16MRN1

Agencies

[Federal Register Volume 80, Number 50 (Monday, March 16, 2015)]
[Notices]
[Page 13563]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-05826]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID SBIR--Technology Transfer 
Direct Phase II (SBIR-TT) (R44).
    Date: April 7, 2015.
    Time: 11:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Thomas F. Conway, Scientific Review Officer, 
Scientific Review Program, DEA/NIAID/NIH/DHHS, 5601 Fishers, 
Rockville, MD 20892, 240-669-5069, thomas.conway@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: March 10, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-05826 Filed 3-13-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.